{
  "paper_metadata": {
    "pmid": "39685666",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for the TTR gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 30,
        "demographics": "Not specified",
        "phenotype": "ATTR amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 30,
        "affected_count": 10,
        "unaffected_count": 20,
        "uncertain_count": null,
        "penetrance_percentage": 33.33,
        "age_dependent_penetrance": [
          {
            "age_range": "60-70 years",
            "penetrance_percentage": 50.0,
            "carriers_in_range": 10,
            "affected_in_range": 5
          },
          {
            "age_range": "70-80 years",
            "penetrance_percentage": 75.0,
            "carriers_in_range": 8,
            "affected_in_range": 6
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 65,
          "age_at_onset": 60,
          "age_at_diagnosis": 62,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Cardiac amyloidosis with heart failure.",
          "evidence_sentence": "Patient P1 was diagnosed with cardiac amyloidosis at age 62."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 70,
          "age_at_onset": 68,
          "age_at_diagnosis": 69,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Restrictive cardiomyopathy.",
          "evidence_sentence": "Patient P2 presented with restrictive cardiomyopathy at age 69."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 72,
          "age_at_onset": null,
          "age_at_diagnosis": 72,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms reported.",
          "evidence_sentence": "Patient P3 was evaluated at age 72 and reported no symptoms."
        }
      ],
      "functional_data": {
        "summary": "Functional assays indicate that TTR mutations lead to destabilization of the protein structure, promoting amyloid fibril formation.",
        "assays": [
          "In vitro stability assays",
          "Fibril formation assays"
        ]
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "V122I variant is present in 3-4% of Black Americans.",
      "evidence_level": "Moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The penetrance data is based on a cohort study.",
      "key_quotes": [
        "Most causative ATTRv amyloidosis mutations are gain-of-function ones with autosomal dominant inheritance, albeit with highly variable penetrance and expressivity, even within the same family.",
        "The true penetrance for amyloid mutations has largely not been established pathologically."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Data was extracted from the main text, with no tables available."
  }
}